Boucher, Michel
624  Ergebnisse:
Personensuche X
?
2

Optimal Duration of Dual Antiplatelet Therapy Following Per..:

Elliott, Jesse ; Kelly, Shannon E. ; Bai, Zemin...
Canadian Journal of Cardiology.  35 (2019)  8 - p. 1039-1046 , 2019
 
?
4

ENVIRONMENTAL SCAN ON PHARMACEUTICALS REQUIRING COMPANION D..:

Cowling, Tara ; Boucher, Michel
International Journal of Technology Assessment in Health Care.  32 (2016)  5 - p. 327-336 , 2016
 
?
5

Teaching "trans issues": An intersectional and systems‐base..:

Boucher, Michel J.
New Directions for Teaching and Learning.  2011 (2011)  125 - p. 65-75 , 2011
 
?
6

Priority setting for health technology assessment at CADTH:

Husereau, Don ; Boucher, Michel ; Noorani, Hussein
International Journal of Technology Assessment in Health Care.  26 (2010)  3 - p. 341-347 , 2010
 
?
7

The uptake of technologies designed to influence medication..:

Saginur, Michael ; Graham, Ian D. ; Forster, Alan J...
Journal of Evaluation in Clinical Practice.  14 (2008)  1 - p. 27-35 , 2008
 
?
9

Ximelagatran: A new type of oral anticoagulant:

Kwok, Lisa ; Molckovsky, Dana ; Boucher, Michel
International Journal of Technology Assessment in Health Care.  21 (2005)  4 - p. 480-486 , 2005
 
?
11

Shifting from Inpatient to Outpatient Treatment of Deep Vei..:

Boucher, Michel ; Rodger, Marc ; Johnson, Jeffrey A..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  23 (2003)  3 - p. 301-309 , 2003
 
1-15